Modified ESHAP as salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma: results of a single-center study of 32 patients. Modified etoposide, methylprednisolone, cytarabine and cisplatin (Q33345621)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Modified ESHAP as salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma: results of a single-center study of 32 patients. Modified etoposide, methylprednisolone, cytarabine and cisplatin |
scientific article |
Statements
1 reference
Modified ESHAP as salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma: results of a single-center study of 32 patients. Modified etoposide, methylprednisolone, cytarabine and cisplatin (English)
1 reference
Mehmet Akif Oztürk
1 reference
Ibrahim Barişta
1 reference
M Kadri Altundağ
1 reference
Alev Türker
1 reference
Suayib Yalçin
1 reference
Ibrahim Güllü
1 reference
Nilüfer Güler
1 reference
Yavuz Ozişik
1 reference
Ayşe Kars
1 reference
Emin Kansu
1 reference
Eşmen Baltali
1 reference
Gülten Tekuzman
1 reference
1 December 2002
1 reference
1 reference
48
1 reference
252-258
1 reference
Identifiers
1 reference
1 reference